BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2500528)

  • 1. Synthesis, mechanism of action, and biological evaluation of mitosenes.
    Orlemans EO; Verboom W; Scheltinga MW; Reinhoudt DN; Lelieveld P; Fiebig HH; Winterhalter BR; Double JA; Bibby MC
    J Med Chem; 1989 Jul; 32(7):1612-20. PubMed ID: 2500528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bioreductive mitosene and mitosane analogues of mitomycin C.
    Verboom W; Reinhoudt DN; Lammerink BH; Orlemans EO; van Veggel FC; Lelieveld P
    Anticancer Drug Des; 1987 Dec; 2(3):271-7. PubMed ID: 3130071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antineoplastic activity of mitosene analogues of the mitomycins.
    Hodges JC; Remers WA; Bradner WT
    J Med Chem; 1981 Oct; 24(10):1184-91. PubMed ID: 7328580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductive activation of potential antitumor mitosene compounds.
    Maliepaard M; de Mol NJ; Janssen LH; Hoogvliet JC; van der Neut W; Verboom W; Reinhoudt DN
    J Med Chem; 1993 Jul; 36(15):2091-7. PubMed ID: 8340912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipophilicity in the in vitro antitumour activity of a series of new mitosene compounds.
    Maliepaard M; de Mol NJ; Janssen LH; van der Neut W; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1992 Oct; 7(5):415-25. PubMed ID: 1388632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin antibiotics. Synthesis and activity of 1,2-disubstituted mitosenes.
    Taylor WG; Leadbetter G; Fost DL; Remers WA
    J Med Chem; 1977 Jan; 20(1):138-41. PubMed ID: 833812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional nucleotide derivatives of mitosenes. Synthesis and activity against parental and multidrug resistant L1210 leukemia.
    Iyengar BS; Dorr RT; Remers WA
    J Med Chem; 1991 Jul; 34(7):1947-51. PubMed ID: 1906107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular interaction and in vitro antitumor effect of various mitomycin C prodrugs in mitomycin C-resistant L1210 leukemia cell lines.
    Matsumoto S; Shigeoka T; Takakura Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3792-9. PubMed ID: 3124967
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitosene-DNA adducts. Characterization of two major DNA monoadducts formed by 1,10-bis(acetoxy)-7-methoxymitosene upon reductive activation.
    Maliepaard M; de Mol NJ; Tomasz M; Gargiulo D; Janssen LH; van Duynhoven JP; van Velzen EJ; Verboom W; Reinhoudt DN
    Biochemistry; 1997 Jul; 36(30):9211-20. PubMed ID: 9230054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential antitumour mitosenes: relationship between in vitro DNA interstrand cross-link formation and DNA damage in Escherichia coli K-12 strains.
    Maliepaard M; Sitters KA; de Mol NJ; Janssen LH; Stratford IJ; Stephens M; Verboom W; Reinhoudt DN
    Biochem Pharmacol; 1994 Oct; 48(7):1371-7. PubMed ID: 7945435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of 6-substituted mitosene analogues of the mitomycins.
    Casner ML; Remers WA; Bradner WT
    J Med Chem; 1985 Jul; 28(7):921-6. PubMed ID: 3925147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular interaction and in vitro antitumor activity of lipophilic mitomycin C prodrugs.
    Matsumoto S; Hayashi Y; Hashida M; Sezaki H
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3784-91. PubMed ID: 3124966
    [No Abstract]   [Full Text] [Related]  

  • 13. New 2-substituted indoloquinone mitomycin analogues.
    Iyengar BS; Remers WA; Catino JJ
    J Med Chem; 1989 Aug; 32(8):1866-72. PubMed ID: 2754710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of antitumour mitosenes in non-aqueous and aqueous environment. An electron spin resonance and cyclic voltammetry study.
    Maliepaard M; De Mol NJ; Janssen LH; Goeptar AR; Te Koppele JM; Vermeulen NP; Verboom W; Reinhoudt DN
    Free Radic Res; 1995 Feb; 22(2):109-21. PubMed ID: 7704182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New potent mitomycin derivatives: synthesis and antitumor activity of 7,7-(ethylenedioxy)mitomycins.
    Kanda Y; Arai H; Ashizawa T; Morimoto M; Kasai M
    J Med Chem; 1992 Jul; 35(15):2781-6. PubMed ID: 1495011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of mechanisms proposed for the conversion of mitomycins into mitosenes.
    Iyengar BS; Remers WA
    J Med Chem; 1985 Jul; 28(7):963-7. PubMed ID: 3925148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of new dimeric mitomycin derivatives; 7-N,7'-N'-bis(omega-thioalkyl)dimitomycins.
    Kono M; Saitoh Y; Kasai M; Shirahata K; Morimoto M; Ashizawa T
    J Antibiot (Tokyo); 1993 Sep; 46(9):1428-38. PubMed ID: 8226321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FR900482, a close cousin of mitomycin C that exploits mitosene-based DNA cross-linking.
    Williams RM; Rajski SR; Rollins SB
    Chem Biol; 1997 Feb; 4(2):127-37. PubMed ID: 9190287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleotide derivatives of 2,7-diaminomitosene.
    Iyengar BS; Dorr RT; Remers WA; Kowal CD
    J Med Chem; 1988 Aug; 31(8):1579-85. PubMed ID: 3397995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of novel mitomycin derivatives containing functional groups at the C-6-methyl position.
    Arai H; Kanda Y; Ashizawa T; Morimoto M; Gomi K; Kono M; Kasai M
    J Med Chem; 1994 Jun; 37(12):1794-804. PubMed ID: 8021918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.